Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States.
CONCLUSION: There is heterogeneity in sequencing strategies that limit the ability to conduct robust comparative effectiveness research. Since few patients follow a similar treatment trajectory, comparative effectiveness research will be challenged to identify treatment sequences with sufficient sample size.
PMID: 33337945 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Electronic Health Records (EHR) | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study | USA Health